<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d28">
    <sentence id="DDI-DrugBank.d28.s0" text="Interactions between COPAXONE  and other drugs have not been fully evaluated.">
        <entity charOffset="21-28" id="DDI-DrugBank.d28.s0.e0" text="COPAXONE" type="brand"/>
    <negationtags>Interactions between COPAXONE and other drugs have &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; been fully evaluated. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d28.s1" text="Results from existing clinical trials suggest no significant interactions between COPAXONE  and other therapies commonly used in MS patients, including the concurrent use of corticosteroids for up to 28 days.">
        <entity charOffset="82-89" id="DDI-DrugBank.d28.s1.e0" text="COPAXONE" type="brand"/>
        <entity charOffset="174-188" id="DDI-DrugBank.d28.s1.e1" text="corticosteroids" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d28.s1.e0" e2="DDI-DrugBank.d28.s1.e1" id="DDI-DrugBank.d28.s1.p0"/>
    <negationtags>Results from existing clinical trials suggest &lt;scope&gt; &lt;cue&gt; no significant &lt;/cue&gt; interactions between COPAXONE and other therapies commonly used in MS patients, including the concurrent use of corticosteroids for up to 28 days. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d28.s2" text="COPAXONE  has not been formally evaluated in combination with Interferon beta.">
        <entity charOffset="0-7" id="DDI-DrugBank.d28.s2.e0" text="COPAXONE" type="brand"/>
        <entity charOffset="62-76" id="DDI-DrugBank.d28.s2.e1" text="Interferon beta" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d28.s2.e0" e2="DDI-DrugBank.d28.s2.e1" id="DDI-DrugBank.d28.s2.p0"/>
    <negationtags>COPAXONE has &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; been formally evaluated in combination with Interferon beta. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d28.s3" text="However, 10 patients who switched from therapy with Interferon beta to COPAXONE  did not report any serious and unexpected adverse reactions thought to be related to treatment.">
        <entity charOffset="52-66" id="DDI-DrugBank.d28.s3.e0" text="Interferon beta" type="drug"/>
        <entity charOffset="71-78" id="DDI-DrugBank.d28.s3.e1" text="COPAXONE" type="brand"/>
        <pair ddi="false" e1="DDI-DrugBank.d28.s3.e0" e2="DDI-DrugBank.d28.s3.e1" id="DDI-DrugBank.d28.s3.p0"/>
    <negationtags>However, 10 patients who switched from therapy with Interferon beta to COPAXONE did &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; report any serious and unexpected adverse reactions thought to be related to treatment. &lt;/scope&gt;</negationtags></sentence>
</document>